We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-3.27%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$21.8B
AUM Growth
-$587M
Cap. Flow
+$493M
Cap. Flow %
2.27%
Top 10 Hldgs %
19.92%
Holding
3,387
New
221
Increased
1,507
Reduced
1,346
Closed
231

Sector Composition

Rank Sector Weight
1 Technology 9.85%
2 Financials 4.83%
3 Consumer Discretionary 4.67%
4 Healthcare 3.78%
5 Industrials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDTX icon
3101
Black Diamond Therapeutics
BDTX
$121M
$31K ﹤0.01%
11,231
+200
+2% +$730
GSAT icon
3102
Globalstar
GSAT
$10.8B
$31K ﹤0.01%
1,403
-498
-26% -$8.47K
XELA
3103
DELISTED
Exela Technologies, Inc. Common Stock
XELA
$31K ﹤0.01%
19
+1
+6% +$2.51K
REFR icon
3104
Research Frontiers
REFR
$16.8M
$29K ﹤0.01%
15,166
-1,666
-10% -$3.06K
AXU
3105
DELISTED
Alexco Resource Corp
AXU
$27K ﹤0.01%
17,578
-77,468
-82% -$129K
SHCR
3106
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$26K ﹤0.01%
+10,370
New +$34.1K
MMAT
3107
DELISTED
Meta Materials Inc. Common Stock
MMAT
$26K ﹤0.01%
154
+54
+54% +$10.1K
PSFE.WS
3108
DELISTED
Paysafe Ltd Warrants
PSFE.WS
$24K ﹤0.01%
45,000
+16,500
+58% +$9.56K
CFMS
3109
DELISTED
Conformis, Inc. Common Stock
CFMS
$24K ﹤0.01%
1,524
-4
-0.3% -$66
NGD
3110
DELISTED
New Gold Inc
NGD
$23K ﹤0.01%
13,019
-550
-4% -$945
ADNWW
3111
DELISTED
Advent Technologies Holdings Warrant
ADNWW
$22K ﹤0.01%
48,500
+500
+1% +$315
MDVL
3112
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$22K ﹤0.01%
+462
New +$27.8K
STAB
3113
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
$22K ﹤0.01%
70,246
+10,211
+17% +$10.9K
VHC icon
3114
VirnetX Holding Corp
VHC
$65.8M
$21K ﹤0.01%
641
+75
+13% +$3.06K
BIOR
3115
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$18K ﹤0.01%
+60
New +$22.8K
RAVE icon
3116
RAVE Restaurant Group
RAVE
$43.9M
$17K ﹤0.01%
15,499
UAVS icon
3117
AgEagle Aerial Systems
UAVS
$55.5M
$17K ﹤0.01%
+14
New +$16.5K
GNLN icon
3118
Greenlane Holdings
GNLN
$1.19M
0
VERO
3119
DELISTED
Venus Concept
VERO
$16K ﹤0.01%
68
TRVN
3120
DELISTED
Trevena, Inc.
TRVN
$16K ﹤0.01%
+45
New +$14.2K
SGTX
3121
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$16K ﹤0.01%
+845
New +$18.8K
HIL
3122
DELISTED
Hill International, Inc. Common Stock
HIL
$16K ﹤0.01%
10,000
MILE
3123
DELISTED
Metromile, Inc. Common Stock
MILE
$16K ﹤0.01%
+12,172
New +$17.6K
NAK
3124
Northern Dynasty Minerals
NAK
$953M
$14K ﹤0.01%
33,100
FEED
3125
ENvue Medical Inc
FEED
$3.79M
$14K ﹤0.01%
6

Similar funds

Cambridge Investment Research Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Cambridge Investment Research Advisors held 3,387 positions worth $21.8B, down 2.6% from $22.4B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors's Q1 2022 filing shows 221 new, 1,507 increased, 1,346 reduced and 231 closed positions. Its largest new stake was Alarm.com: 285,954 shares worth $19M. The largest sale was iShares Core S&P US Growth ETF, an estimated $43.9M.

By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 10% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cambridge Investment Research Advisors's largest Q1 2022 buy was Alarm.com: 285,954 shares worth $19M.
  • Cambridge Investment Research Advisors added most to iShares 0-1 Year Treasury Bond ETF in Q1 2022, an estimated $52.6M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2022 reduction was iShares Core S&P US Growth ETF, cutting an estimated $43.9M.
  • Cambridge Investment Research Advisors fully exited Royal Dutch Shell PLC ADS Class A in Q1 2022, selling an estimated $3.6M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $21.8B portfolio in Q1 2022.
  • Cambridge Investment Research Advisors opened 221 new positions and closed 231 in Q1 2022.
  • Cambridge Investment Research Advisors's portfolio value fell 2.6% quarter-over-quarter to $21.8B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2022, filed 12 May 2022.